1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6A00E3C2B47519FE000258B7B004EE86E
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/A00E3C2B47519FE000258B7B004EE86E?OpenDocument
18
19OpenDocument
2018.97.14.80
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Medical Affairs » Launch Optimization

Document Excerpt: Medical Affairs Product Launch in CNS / Neurosciences: Roles, Collaboration, and Evolution

DB Image

ID: MD-918


Features:

7 Info Graphics

15 Data Graphics

300+ Metrics

18 Narratives


Pages/Slides: 4


Published: 2024


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "Download Free Excerpt".

To return to the study abstract to purchase the full study -
click here

This excerpt includes research findings and metrics from document #5818 “Medical Affairs Product Launch in CNS / Neurosciences: Roles, Collaboration, and Evolution”.

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Biotech; Diagnostic; Chemical; Health Care; Consulting; Communications; Consumer Products; Medical Device


Companies Profiled:
Adamas Pharmaceuticals; Apellis Pharmaceuticals; AstraZeneca; BELLUS Health; BIAL; bioMerieux; Boehringer Ingelheim; EMD Serono; Eurofarma; Genentech; Gedeon Richter ; GW Pharmaceuticals; Ipsen; Kyowa Kirin; Labaid Group; Lundbeck; MEDiSTRAVA; Merck KGaA; NexGen Healthcare Communications; Novartis; Pixacore; Sandoz; Sunovion; Takeda Pharmaceuticals; Terumo BCT: Terumo Blood and Cell Technologies

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.